Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;34(4):697-702.
doi: 10.1007/s12288-018-0962-9. Epub 2018 May 24.

Immunomodulatory Effects of Blood Transfusion on Tumor Size, Metastasis, and Survival in Experimental Fibrosarcoma

Affiliations

Immunomodulatory Effects of Blood Transfusion on Tumor Size, Metastasis, and Survival in Experimental Fibrosarcoma

Kamal Abdolmohammadi et al. Indian J Hematol Blood Transfus. 2018 Oct.

Abstract

In spite of efforts, blood transfusion is still accompanied with adverse effects such as transfusion-related immunomodulation (TRIM). The current study aimed to evaluate the effects of allogeneic, syngeneic, fresh and storage blood transfusion on the growth and metastasis of tumors and survival in fibrosarcoma bearing BALB/c mice. Twenty-five BALB/c mice were grouped into five groups of equal size. All groups were injected 1.2 × 106 WEHI-164 cells subcutaneously to induce fibrosarcoma tumor. After expansion of the tumor, in four groups (except for the control group), hemorrhage-induced anemia was developed. Twenty-four hours later, blood deficit was replaced by fresh allogeneic, storage allogeneic, fresh syngeneic and storage syngeneic blood transfusion, respectively. After a blood transfusion, for 13 days, the tumor size and survival of the mice were evaluated. In the day 20, the mice were sacrificed and their spleen tissues were evaluated for TRIM induced metastasis. Tumor size increase in the groups that received allogeneic (fresh and storage) and storage syngeneic blood transfusion was significantly higher than the control group (P value < 0.05). However, no significant difference was present in survival between the experiment groups and the control group. There was no metastasis in none of groups at the end of the study. Allogeneic and storage blood transfusion could have immunomodulatory effects such as increased tumor size. However, it seems that fresh and syngeneic blood transfusion have no effects on tumor growth in fibrosarcoma bearing mice. Further evidence may prove that more attention is warranted in blood transfusion into cancer cases.

Keywords: Blood transfusion; Fibrosarcoma; Immunomodulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.All procedures performed in studies involving animals were in accordance with the ethical standards of the Tarbiat Modares University.

Figures

Fig. 1
Fig. 1
Study design
Fig. 2
Fig. 2
The effect of blood transfusion on tumor size between control and overall (the left) and each (the right) blood transfusion group. Mean ± SD are shown. *Significant at 0.05, **significant at 0.01
Fig. 3
Fig. 3
Kaplan–Meier survival curves for control and blood transfusion groups

Similar articles

Cited by

References

    1. Brown CJ, Navarrete CV. Clinical relevance of the HLA system in blood transfusion. Vox Sang. 2011;101(2):93–105. doi: 10.1111/j.1423-0410.2011.01474.x. - DOI - PubMed
    1. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97(5):1180–1195. doi: 10.1182/blood.V97.5.1180. - DOI - PubMed
    1. Lin H-S, Samy RN, Lum J, Dorie MJ, Terris DJ. Effect of blood transfusion in an experimental sarcoma model. Arch Otolaryngol Head Neck Surg. 2002;128(3):308–312. doi: 10.1001/archotol.128.3.308. - DOI - PubMed
    1. Sun K, D’Alessandro A, Xia Y. Purinergic control of red blood cell metabolism: novel strategies to improve red cell storage quality. Blood Transfus. 2017;15(6):535. - PMC - PubMed
    1. Greenwalt T. A short history of transfusion medicine. Transfusion. 1997;37(5):550–563. doi: 10.1046/j.1537-2995.1997.37597293889.x. - DOI - PubMed

LinkOut - more resources